BIO SB WT1 (6F-H2), MMab
For In Vitro Diagnostic Use
Description
Wilms’ Tumor Protein (WT1) is a suppressor gene located on Chromosome 11p13. Mutations of the WT1 gene on Chromosome 11 are observed in approximately 20% of Wilms tumors. At least half of the Wilms tumors with mutations in WT1 also carry mutations in CTNNB1, the gene encoding the proto-oncogene beta-catenin. Wilms’ tumor is a neoplasm of the kidneys that typically occurs in children. It is also known as a Nephroblastoma. WT1 antibody expression has been identified in proliferative mesothelial cells, Malignant Mesothelioma, Ovarian Cystadenocarcinoma, Gonadoblastoma, Nephroblastoma and Desmoplastic Small Round Cell Tumor. Lung Adenocarcinomas rarely stain positive with this antibody.
Synonymes
WT1, anti-WT1, anti WT1, GUD, WAGR, Wilms tumor 1, Wilms tumor protein, WIT 2, WT33, AWT1, NPHS4, amino terminal domain of EWS last three zinc fingers of the DNA binding domain of WT1, EWS WT1, anti-wt1, wt-1, anti-wt-1, anti wt1, anti wt-1, wt 1, anti-wt 1
Caractéristiques
- Type
- Mouse Monoclonal
- Clone
- 6F-H2
- Isotype
- IgG1/K
- Réactivité
- Paraffin, Frozen
- Localisation
- Nuclear
- Contrôle
- Testicle, Fallopian Tube, Kidney, Malignant Mesothelioma
- Usage prévu
- For In Vitro Diagnostic Use
Intéressé par ce produit ?
Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.